More News

01 Dec 2017 Astellas Acquires Mitobridge Under Existing Collaboration
30 Nov 2017 MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab
29 Nov 2017 Regeneron and Decibel Therapeutics Announce Strategic Collaboration to Discover and Develop Therapeutics for Hearing Loss and Tinnitus
29 Nov 2017 Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company
28 Nov 2017 X-Chem and Gilead Announce Drug Discovery Collaboration
28 Nov 2017 PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor
28 Nov 2017 Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350
27 Nov 2017 HITGEN and Boehringer Ingelheim Enter DNA-Encoded Library Based Drug Discovery Research Collaboration
27 Nov 2017 Medeor Therapeutics Raises $57 Million In Series B Financing
27 Nov 2017 Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis
27 Nov 2017 Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
21 Nov 2017 Step Pharma Completes €14.5 million Series A Financing with Additional New Investor
21 Nov 2017 Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax™
20 Nov 2017 PeptiDream Announces Discovery Collaboration Agreement with Bayer
17 Nov 2017 Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases
17 Nov 2017 Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®
17 Nov 2017 Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen
15 Nov 2017 Arvinas Expands Strategic License Agreement with Genentech
15 Nov 2017 ITUS Corporation Licenses CAR-T Technology from The Wistar Institute
15 Nov 2017 Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team
15 Nov 2017 Monopar Therapeutics, Inc. Announces Acquisition of GPX-150, a Broad Spectrum Phase II Cancer Drug Candidate, Closing on $9.7M in Financing, and Filing of Form 10 Registration Statement
15 Nov 2017 Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
15 Nov 2017 Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials
15 Nov 2017 Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
15 Nov 2017 Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top